NCT05807984Not yet recruitingPhase 2
Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion
A Prospective Phase II Clinical Study of Carbon Ion Re-irradiation in Unresectable Locally Recurrent Rectal Cancer
Source: ClinicalTrials.gov · Last updated 11 Apr 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Prospective phase II clinical study aim to explore the clinical outcome of patients with unresectable locally recurrent rectal cancer (LRRC) treated with re-irradiation by carbon ion radiotherapy (CIRT)
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (estimated)
- First submitted
- 16 Feb 2023
- Start date
- 1 May 2023
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Xin Cai
- Diseases
- Colorectal cancer
- NCT number
- NCT05807984
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 31
- From 1 May 2023 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\) received more than once prior radiotherapy in the same treatment field,
- 2\) time to the last radiotherapy was \<1 year,
Other
- 3\) space between the lesion to organ at risk (OARs) (bladder or digestive tract) was too close (\<5 mm).
Who the study is looking for
- 1\) pathologically confirmed rectal adenocarcinoma (including mucinous adenocarcinoma and signet-ring cell carcinoma) and LRRC confirmed by biopsy or clinical diagnosis,
- 2\) received a radical operation for their primary tumor and regional lymph nodes,
- 3\) received chemo-radiation or radiation in pelvic before CIRT,
- 4\) received re-irradiation by CIRT after their pelvic radiotherapy.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Proton and Heavy Ion Center Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.